Cargando…

The cost of inpatient death associated with acute coronary syndrome

BACKGROUND: No studies have addressed the cost of inpatient mortality during an acute coronary syndrome (ACS) admission. OBJECTIVE: Compare ACS-related length of stay (LOS), total admission cost, and total admission cost by day of discharge/death for patients who died during an inpatient admission w...

Descripción completa

Detalles Bibliográficos
Autores principales: Page, Robert L, Ghushchyan, Vahram, Van Den Bos, Jill, Gray, Travis J, Hoetzer, Greta L, Bhandary, Durgesh, Nair, Kavita V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745827/
https://www.ncbi.nlm.nih.gov/pubmed/26893568
http://dx.doi.org/10.2147/VHRM.S94026
_version_ 1782414727393050624
author Page, Robert L
Ghushchyan, Vahram
Van Den Bos, Jill
Gray, Travis J
Hoetzer, Greta L
Bhandary, Durgesh
Nair, Kavita V
author_facet Page, Robert L
Ghushchyan, Vahram
Van Den Bos, Jill
Gray, Travis J
Hoetzer, Greta L
Bhandary, Durgesh
Nair, Kavita V
author_sort Page, Robert L
collection PubMed
description BACKGROUND: No studies have addressed the cost of inpatient mortality during an acute coronary syndrome (ACS) admission. OBJECTIVE: Compare ACS-related length of stay (LOS), total admission cost, and total admission cost by day of discharge/death for patients who died during an inpatient admission with a matched cohort discharged alive following an ACS-related inpatient stay. METHODS: Medical and pharmacy claims (2009–2012) were used to identify admissions with a primary diagnosis of ACS from patients with at least 6 months of continuous enrollment prior to an ACS admission. Patients who died during their ACS admission (deceased cohort) were matched (one-to-one) to those who survived (survived cohort) on age, sex, year of admission, Chronic Condition Index score, and prior revascularization. Mean LOS, total admission cost, and total admission cost by the day of discharge/death for the deceased cohort were compared with the survived cohort. A generalized linear model with log transformation was used to estimate the differences in the total expected incremental cost of an ACS admission and by the day of discharge/death between cohorts. A negative binomial model was used to estimate differences in the LOS between the two cohorts. Costs were inflated to 2013 dollars. RESULTS: A total of 1,320 ACS claims from patients who died (n=1,320) were identified and matched to 1,319 claims from the survived patients (n=1,319). The majority were men (68%) and mean age was 56.7±6.4 years. The LOS per claim for the deceased cohort was 47% higher (adjusted incidence rate ratio: 1.47, 95% confidence interval: 1.37–1.57) compared with claims from the survived cohort. Compared with the survived cohort, the adjusted mean incremental total cost of ACS admission claims from the deceased cohort was US$43,107±US$3,927 (95% confidence interval: US$35,411–US$50,803) higher. CONCLUSION: Despite decreasing ACS hospitalizations, the economic burden of inpatient death remains high.
format Online
Article
Text
id pubmed-4745827
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-47458272016-02-18 The cost of inpatient death associated with acute coronary syndrome Page, Robert L Ghushchyan, Vahram Van Den Bos, Jill Gray, Travis J Hoetzer, Greta L Bhandary, Durgesh Nair, Kavita V Vasc Health Risk Manag Original Research BACKGROUND: No studies have addressed the cost of inpatient mortality during an acute coronary syndrome (ACS) admission. OBJECTIVE: Compare ACS-related length of stay (LOS), total admission cost, and total admission cost by day of discharge/death for patients who died during an inpatient admission with a matched cohort discharged alive following an ACS-related inpatient stay. METHODS: Medical and pharmacy claims (2009–2012) were used to identify admissions with a primary diagnosis of ACS from patients with at least 6 months of continuous enrollment prior to an ACS admission. Patients who died during their ACS admission (deceased cohort) were matched (one-to-one) to those who survived (survived cohort) on age, sex, year of admission, Chronic Condition Index score, and prior revascularization. Mean LOS, total admission cost, and total admission cost by the day of discharge/death for the deceased cohort were compared with the survived cohort. A generalized linear model with log transformation was used to estimate the differences in the total expected incremental cost of an ACS admission and by the day of discharge/death between cohorts. A negative binomial model was used to estimate differences in the LOS between the two cohorts. Costs were inflated to 2013 dollars. RESULTS: A total of 1,320 ACS claims from patients who died (n=1,320) were identified and matched to 1,319 claims from the survived patients (n=1,319). The majority were men (68%) and mean age was 56.7±6.4 years. The LOS per claim for the deceased cohort was 47% higher (adjusted incidence rate ratio: 1.47, 95% confidence interval: 1.37–1.57) compared with claims from the survived cohort. Compared with the survived cohort, the adjusted mean incremental total cost of ACS admission claims from the deceased cohort was US$43,107±US$3,927 (95% confidence interval: US$35,411–US$50,803) higher. CONCLUSION: Despite decreasing ACS hospitalizations, the economic burden of inpatient death remains high. Dove Medical Press 2016-02-03 /pmc/articles/PMC4745827/ /pubmed/26893568 http://dx.doi.org/10.2147/VHRM.S94026 Text en © 2016 Page II et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Page, Robert L
Ghushchyan, Vahram
Van Den Bos, Jill
Gray, Travis J
Hoetzer, Greta L
Bhandary, Durgesh
Nair, Kavita V
The cost of inpatient death associated with acute coronary syndrome
title The cost of inpatient death associated with acute coronary syndrome
title_full The cost of inpatient death associated with acute coronary syndrome
title_fullStr The cost of inpatient death associated with acute coronary syndrome
title_full_unstemmed The cost of inpatient death associated with acute coronary syndrome
title_short The cost of inpatient death associated with acute coronary syndrome
title_sort cost of inpatient death associated with acute coronary syndrome
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745827/
https://www.ncbi.nlm.nih.gov/pubmed/26893568
http://dx.doi.org/10.2147/VHRM.S94026
work_keys_str_mv AT pagerobertl thecostofinpatientdeathassociatedwithacutecoronarysyndrome
AT ghushchyanvahram thecostofinpatientdeathassociatedwithacutecoronarysyndrome
AT vandenbosjill thecostofinpatientdeathassociatedwithacutecoronarysyndrome
AT graytravisj thecostofinpatientdeathassociatedwithacutecoronarysyndrome
AT hoetzergretal thecostofinpatientdeathassociatedwithacutecoronarysyndrome
AT bhandarydurgesh thecostofinpatientdeathassociatedwithacutecoronarysyndrome
AT nairkavitav thecostofinpatientdeathassociatedwithacutecoronarysyndrome
AT pagerobertl costofinpatientdeathassociatedwithacutecoronarysyndrome
AT ghushchyanvahram costofinpatientdeathassociatedwithacutecoronarysyndrome
AT vandenbosjill costofinpatientdeathassociatedwithacutecoronarysyndrome
AT graytravisj costofinpatientdeathassociatedwithacutecoronarysyndrome
AT hoetzergretal costofinpatientdeathassociatedwithacutecoronarysyndrome
AT bhandarydurgesh costofinpatientdeathassociatedwithacutecoronarysyndrome
AT nairkavitav costofinpatientdeathassociatedwithacutecoronarysyndrome